The Head and Neck Cancer Diagnostics Market size in the Middle East & Africa is estimated to grow with a CAGR of 8.16% during the forecast period.
Head and Neck cancer is one of the ten most predominant cancers prevailing worldwide. High alcohol consumption and tobacco intake worldwide are the main cause of this cancer and are most prevalent in regions with high consumption. Early-stage cancer detection and prompt treatment play a crucial role in offering the best chance for curing the diseases. Therefore, more procedures for diagnosing head and neck cancer, particularly pharyngeal and oral cancers, induce growth in the market.
With the increase in the demand for diagnostic imaging, innovation in treatment modes, and the incorporation of novel technologies in diagnostic equipment, the market is expected to grow during the forecast period. Furthermore, with an increase in disease incidence, the head and neck cancer market diagnostics are expected to rise year on year. Proper detection at an early stage can lead to proper treatment and long, healthier life.
In the African Subcontinent, South Africa and Namibia have the highest incidences f oral cancer, with death rates above 6 per 100000 people. Other countries like Sudan, Kenya, Tanzania, and Uganda also have high death rates due to oral cancer. These regions have a higher incidence of the disease due to the increased intake of tobacco products and Alcohol.
The rise in the aging population increased chronic diseases, especially head and neck related cancers, increased awareness towards cancer, and a rise in people and government's healthcare expenditure. However, Low Adoption Rate of Digital Technology-Based Systems, Conventional CT and MRI Scanners, Excise Duty Imposed on Sale of Medical Devices in Mature Markets.
This research report on the Middle East and Africa head and neck cancer diagnostics market has been segmented and sub-segmented into the following categories:
By Test Type:
With the growing scale of healthcare centers equipped with cutting-edge technology, the Middle East and Africa are expected to have significant growth potential in the next few years. One of the ten most common types of cancer globally is head and neck cancer. The main causes of this cancer include high alcohol and cigarette usage, which are especially prevalent in locations where consumption is high. Early detection of cancer and timely treatment are critical for providing the best possibility of curing the diseases. The market is also expected to grow due to an increase in the number of procedures for diagnosing head and neck cancer, notably pharyngeal and oral malignancies. In addition, the market is likely to expand over the forecast period due to rising demand for diagnostic imaging, treatment modality innovation, and the incorporation of novel technologies in diagnostic equipment.
The head and neck cancer diagnostics market in MEA is predicted to grow yearly because of an increase in disease incidence. Early detection and treatment can result in longer, healthier life. Oral cancer is the most common cancer on the African continent, with death rates above 6 per 100,000 individuals in South Africa and Namibia. Oral cancer is also a leading cause of death in other countries like Sudan, Kenya, Tanzania, and Uganda. Because of the increased consumption of cigarettes and alcohol in these areas, the disease is more prevalent.
KEY MARKET PLAYERS:
Companies playing a prominent role in the MEA Head and Neck Cancer Diagnostics Market profiled in this report are Philips Healthcare, GE Healthcare, Varian Siemens Healthcare, Medical Systems, Shimadzu Corporation, Velscope VX, Identafi, and AdDent Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com